| Product Code: ETC6743895 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Gastric Cancer Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 China Gastric Cancer Market - Industry Life Cycle |
3.4 China Gastric Cancer Market - Porter's Five Forces |
3.5 China Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 China Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 China Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 China Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 China Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 China Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of gastric cancer in China |
4.2.2 Growing awareness and screening programs for early detection of gastric cancer |
4.2.3 Advancements in diagnostic technologies for gastric cancer |
4.3 Market Restraints |
4.3.1 Limited access to quality healthcare services in rural areas of China |
4.3.2 High treatment costs associated with gastric cancer care |
4.3.3 Presence of alternative traditional medicine practices affecting conventional treatment adoption |
5 China Gastric Cancer Market Trends |
6 China Gastric Cancer Market, By Types |
6.1 China Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 China Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 China Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 China Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 China Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 China Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 China Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 China Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 China Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 China Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 China Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 China Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 China Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 China Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 China Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 China Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 China Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 China Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 China Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 China Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 China Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 China Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 China Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 China Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 China Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 China Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 China Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 China Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 China Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 China Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 China Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 China Gastric Cancer Market Import-Export Trade Statistics |
7.1 China Gastric Cancer Market Export to Major Countries |
7.2 China Gastric Cancer Market Imports from Major Countries |
8 China Gastric Cancer Market Key Performance Indicators |
8.1 Survival rates of gastric cancer patients in China |
8.2 Adoption rates of advanced treatment modalities for gastric cancer |
8.3 Participation rates in gastric cancer screening programs |
8.4 Research and development investments in innovative gastric cancer therapies |
8.5 Patient satisfaction levels with gastric cancer care services |
9 China Gastric Cancer Market - Opportunity Assessment |
9.1 China Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 China Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 China Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 China Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 China Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 China Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Gastric Cancer Market - Competitive Landscape |
10.1 China Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 China Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here